ADI

Today, 25 July 2025, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending donanemab (Kisunla) for the treatment of early symptomatic Alzheimer's disease in adults with confirmed amyloid pathology…

This week, ADI CEO Paola Barbarino has published an opinion piece in Nature titled “Dementia is deadly — the UN needs to take it more seriously”. See the article: nature.com/articles/d4158… In the article, Paola underscores the importance of multinational bodies, like the United…

Thank you to everyone who joined us for our crucial webinar, 'Enhancing Dementia Education Through Global Best Practices', on 22 July. If you missed this important discussion or wish to revisit the valuable insights shared, the full recording is now available on ADI’s YouTube…

ADI would like to give a very warm welcome to our new country associations and new board members, as voted on at the ADI Council Meeting on 11 July 2025. We are delighted to welcome new member associations Alzheimer's Ethiopia, St Vincent and the Grenadines Alzheimer’s Disease…

There's still time to join us tomorrow, July 22nd, at 1:00 PM (UK Time), for ADI's crucial webinar on dementia education. REGISTER: bit.ly/40gA73T Discover how fostering knowledge exchange and collaboration can collectively drive progress and elevate care standards for…

There is less than one week left to register for ADI’s latest webinar ‘Enhancing Dementia Education Through Global Best Practices’, taking place on 22 July, 1:00 PM (UK Time). Register today: bit.ly/4neJafy Join us for this insightful webinar as we bring together…

ADI has previously shared the testimonies of people who have been travelling for treatment, based on disparities between regulators. In the coming weeks, we are collecting testimonies of medical practitioners who are providing the latest treatments to people with Alzheimer's…

ADI is pleased to announce that registration for the ADI Global Conference 2026 in Lyon, France, opens today! Learn more and register today: bit.ly/4kvZiXB Join us for the 37th Global Conference of Alzheimer's Disease International, 14-16 April 2026, in Lyon, France!…

ADI is pleased to share the recent @bmj_latest's article on ‘Improving care for people with dementia through co-creation of action plans in the Western Pacific region’ The article is authored by ADI Board Member @emilyong67 and co-authored by Deputy CEO Chris Lynch, Asia…

Today, July 7th, the Scottish Medicines Consortium (SMC) has upheld its decision not to recommend lecanemab for early stage Alzheimer's disease for use within the Scottish National Health Service. This outcome means people living with Alzheimer's and their families in Scotland…

The National Institute for Health and Care Excellence has concluded that the benefits from two treatments for early Alzheimer's Disease, #donanemab and #lecanemab, remain too small to justify the additional cost. The committee concluded that if these treatments were…

ADI has launched the latest campaign toolkits for the upcoming World Alzheimer’s Month global campaign this September. Access a free selection of social media cards, posters, and infographics, as well as useful advice on how to raise awareness about dementia, key statistics, and…

ADI is pleased to note that dementia is referenced in this year’s Civil 7 (C7) Communiqué. As a participating member of the C7 engagement group, comprising a diverse range of civil society organisations, ADI contributed to the development of the Communiqué and ensured that…

The Alzheimer's Disease International team and Board members, including Board Chair Dale Goldhawk, Vice-Chair Meera Pattabiraman, have convened in London, UK for their annual in-person meeting. Also in attendance were Richard Davies, Maree McCabe, Emily Ong, Dr Jesús Rodrigo…

ADI Regional Director for Asia Pacific, @DYSuharya , featured in the Impact Beyond Dialogue, hosted by CNN Indonesia and supported by the Impact Beyond Banking initiative, DBS Indonesia and DBS Foundation: Future-Proofing Indonesia: From Demographic Bonus to Ageing Readiness.…

ADI is pleased to announce that abstract submissions for the upcoming Global Conference of ADI in 2026 are now open! Submit an abstract to showcase your work or research at this international event: bit.ly/4dF5nPr Abstract submissions can be submitted under the…

18 months of advocacy. 5 official statements. Over 200 official letters. That's just some of what made the recent extension to the Global Action Plan on Dementia possible. Last week, ADI was proud to report the unanimous adoption of a 6-year extension to the Global Action Plan…

An action-packed week at the 78th World Health Assembly comes to an end! ADI is proud to have been a high-profile voice during this crucial event, calling for, and achieving the extension to the Global Action Plan on the Public Health Response to Dementia. From the extension, to…